Literature DB >> 25794658

Seasonal risk factors for asthma exacerbations among inner-city children.

Stephen J Teach1, Peter J Gergen2, Stanley J Szefler3, Herman E Mitchell4, Agustin Calatroni4, Jeremy Wildfire4, Gordon R Bloomberg5, Carolyn M Kercsmar6, Andrew H Liu7, Melanie M Makhija8, Elizabeth Matsui9, Wayne Morgan10, George O'Connor11, William W Busse12.   

Abstract

BACKGROUND: Asthma exacerbations remain common, even in children and adolescents, despite optimal medical management. Identification of host risk factors for exacerbations is incomplete, particularly for seasonal episodes.
OBJECTIVE: We sought to define host risk factors for asthma exacerbations unique to their season of occurrence.
METHODS: This is a retrospective analysis of patients aged 6 to 20 years who comprised the control groups of the Asthma Control Evaluation study and the Inner City Anti-IgE Therapy for Asthma study. Univariate and multivariate models were constructed to determine whether patients' demographic and historical factors, allergic sensitization, fraction of exhaled nitric oxide values, spirometric measurements, asthma control, and treatment requirements were associated with seasonal exacerbations.
RESULTS: The analysis included 400 patients (54.5% male; 59.0% African American; median age, 13 years). Exacerbations occurred in 37.5% of participants over the periods of observation and were most common in the fall (28.8% of participants). In univariate analysis impaired pulmonary function was significantly associated with greater odds of exacerbations for all seasons, as was an exacerbation in the previous season for all seasons except spring. In multivariate analysis exacerbation in the previous season was the strongest predictor in fall and winter, whereas a higher requirement for inhaled corticosteroids was the strongest predictor in spring and summer. The multivariate models had the best predictive power for fall exacerbations (30.5% variance attributed).
CONCLUSIONS: Among a large cohort of inner-city children with asthma, patients' risk factors for exacerbation vary by season. Thus information on individual patients might be beneficial in strategies to prevent these seasonal events.
Copyright © 2015 American Academy of Allergy, Asthma & Immunology. All rights reserved.

Entities:  

Keywords:  Asthma; IgE; allergy; asthma exacerbations; biomarkers; eosinophils; exhaled nitric oxide; pulmonary function; seasons

Mesh:

Substances:

Year:  2015        PMID: 25794658      PMCID: PMC4461505          DOI: 10.1016/j.jaci.2014.12.1942

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  32 in total

1.  The role of rhinovirus in asthma exacerbations.

Authors:  Samuel L Friedlander; William W Busse
Journal:  J Allergy Clin Immunol       Date:  2005-08       Impact factor: 10.793

Review 2.  Epidemiology of asthma exacerbations.

Authors:  Malcolm R Sears
Journal:  J Allergy Clin Immunol       Date:  2008-10       Impact factor: 10.793

3.  Asthma exacerbations . 1: epidemiology.

Authors:  N W Johnston; M R Sears
Journal:  Thorax       Date:  2006-08       Impact factor: 9.139

4.  Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial.

Authors:  Stanley J Szefler; Herman Mitchell; Christine A Sorkness; Peter J Gergen; George T O'Connor; Wayne J Morgan; Meyer Kattan; Jacqueline A Pongracic; Stephen J Teach; Gordon R Bloomberg; Peyton A Eggleston; Rebecca S Gruchalla; Carolyn M Kercsmar; Andrew H Liu; Jeremy J Wildfire; Matthew D Curry; William W Busse
Journal:  Lancet       Date:  2008-09-20       Impact factor: 79.321

5.  Human metapneumovirus infection plays an etiologic role in acute asthma exacerbations requiring hospitalization in adults.

Authors:  John V Williams; James E Crowe; Rachel Enriquez; Patricia Minton; R Stokes Peebles; Robert G Hamilton; Stanley Higgins; Marie Griffin; Tina V Hartert
Journal:  J Infect Dis       Date:  2005-08-29       Impact factor: 5.226

6.  Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial.

Authors:  Christine A Sorkness; Robert F Lemanske; David T Mauger; Susan J Boehmer; Vernon M Chinchilli; Fernando D Martinez; Robert C Strunk; Stanley J Szefler; Robert S Zeiger; Leonard B Bacharier; Gordon R Bloomberg; Ronina A Covar; Theresa W Guilbert; Gregory Heldt; Gary Larsen; Michael H Mellon; Wayne J Morgan; Mark H Moss; Joseph D Spahn; Lynn M Taussig
Journal:  J Allergy Clin Immunol       Date:  2006-11-30       Impact factor: 10.793

7.  Recent asthma exacerbations predict future exacerbations in children with severe or difficult-to-treat asthma.

Authors:  Tmirah Haselkorn; Robert S Zeiger; Bradley E Chipps; David R Mink; Stanley J Szefler; F Estelle R Simons; Marc Massanari; James E Fish
Journal:  J Allergy Clin Immunol       Date:  2009-11       Impact factor: 10.793

8.  Factors associated with asthma exacerbations during a long-term clinical trial of controller medications in children.

Authors:  Ronina A Covar; Stanley J Szefler; Robert S Zeiger; Christine A Sorkness; Mark Moss; David T Mauger; Susan J Boehmer; Robert C Strunk; Fernando D Martinez; Lynn M Taussig
Journal:  J Allergy Clin Immunol       Date:  2008-10       Impact factor: 10.793

9.  Prevalence of viral respiratory tract infections in children with asthma.

Authors:  Nino Khetsuriani; N Neely Kazerouni; Dean D Erdman; Xiaoyan Lu; Stephen C Redd; Larry J Anderson; W Gerald Teague
Journal:  J Allergy Clin Immunol       Date:  2006-11-30       Impact factor: 10.793

10.  Understanding the September asthma epidemic.

Authors:  Malcolm R Sears; Neil W Johnston
Journal:  J Allergy Clin Immunol       Date:  2007-07-20       Impact factor: 10.793

View more
  49 in total

Review 1.  The Role of Type 2 Inflammation in the Pathogenesis of Asthma Exacerbations.

Authors:  Eleanor M Dunican; John V Fahy
Journal:  Ann Am Thorac Soc       Date:  2015-11

2.  Examining causes of the urban (inner city) asthma epidemic: Implementing new management strategies.

Authors:  Stanley J Szefler
Journal:  Allergy Asthma Proc       Date:  2016 Jan-Feb       Impact factor: 2.587

3.  Rhinitis in children and adolescents with asthma: Ubiquitous, difficult to control, and associated with asthma outcomes.

Authors:  Alkis Togias; Peter J Gergen; Jack W Hu; Denise C Babineau; Robert A Wood; Robyn T Cohen; Melanie M Makhija; Gurjit K Khurana Hershey; Carolyn M Kercsmar; Rebecca S Gruchalla; Andrew H Liu; Emily Wang; Haejin Kim; Carin I Lamm; Leonard B Bacharier; Dinesh Pillai; Steve M Sigelman; James E Gern; William W Busse
Journal:  J Allergy Clin Immunol       Date:  2018-09-11       Impact factor: 10.793

Review 4.  An Overview of Fractional Exhaled Nitric Oxide and Children with Asthma.

Authors:  Devika R Rao; Wanda Phipatanakul
Journal:  Expert Rev Clin Immunol       Date:  2016-02-19       Impact factor: 4.473

5.  Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations.

Authors:  Stephen J Teach; Michelle A Gill; Alkis Togias; Christine A Sorkness; Samuel J Arbes; Agustin Calatroni; Jeremy J Wildfire; Peter J Gergen; Robyn T Cohen; Jacqueline A Pongracic; Carolyn M Kercsmar; Gurjit K Khurana Hershey; Rebecca S Gruchalla; Andrew H Liu; Edward M Zoratti; Meyer Kattan; Kristine A Grindle; James E Gern; William W Busse; Stanley J Szefler
Journal:  J Allergy Clin Immunol       Date:  2015-10-27       Impact factor: 10.793

6.  Long-term pulmonary complications in perinatally HIV-infected youth.

Authors:  William T Shearer; Denise L Jacobson; Wendy Yu; George K Siberry; Murli Purswani; Suzanne Siminski; Laurie Butler; Erin Leister; Gwendolyn Scott; Russell B Van Dyke; Ram Yogev; Mary E Paul; Ana Puga; Andrew A Colin; Meyer Kattan
Journal:  J Allergy Clin Immunol       Date:  2017-03-06       Impact factor: 10.793

7.  Predictors of asthma exacerbation among patients with poorly controlled asthma despite inhaled corticosteroid treatment.

Authors:  Wilson Quezada; Eun Soo Kwak; Joan Reibman; Linda Rogers; John Mastronarde; William G Teague; Christine Wei; Janet T Holbrook; Emily DiMango
Journal:  Ann Allergy Asthma Immunol       Date:  2015-12-19       Impact factor: 6.347

8.  Enhanced plasmacytoid dendritic cell antiviral responses after omalizumab.

Authors:  Michelle A Gill; Andrew H Liu; Agustin Calatroni; Rebecca Z Krouse; Baomei Shao; Allison Schiltz; James E Gern; Alkis Togias; William W Busse
Journal:  J Allergy Clin Immunol       Date:  2017-09-01       Impact factor: 10.793

9.  Predictors of emergency department use in children with persistent asthma in metropolitan Atlanta, Georgia.

Authors:  Jeffery M Franklin; Jocelyn R Grunwell; Alice C Bruce; Robin C Smith; Anne M Fitzpatrick
Journal:  Ann Allergy Asthma Immunol       Date:  2017-05-04       Impact factor: 6.347

10.  Change in FEV1 and Feno Measurements as Predictors of Future Asthma Outcomes in Children.

Authors:  Shona Fielding; Marielle Pijnenburg; Johan C de Jongste; Katharine C Pike; Graham Roberts; Helen Petsky; Anne B Chang; Maria Fritsch; Thomas Frischer; Stanley Szefler; Peter Gergen; Francoise Vermeulen; Robin Vael; Steve Turner
Journal:  Chest       Date:  2018-10-22       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.